Literature DB >> 16356690

Exploring depression in schizophrenia.

Carlo Maggini1, Andrea Raballo.   

Abstract

BACKGROUND: A consistent amount of empirical research suggests that depression, besides interfering with quality of life and social functioning, may influence other symptom dimensions in schizophrenia, thus constituting an important domain for treatment strategies, outcome, and prognosis. AIM: This study investigated the factorial structure of the Calgary depression scale for schizophrenia (CDSS) in a sample of schizophrenic patients and explored the relationships between such factors, major symptom dimensions and subjective experiences.
METHODS: One hundred and sixty-one subjects were examined to assess the severity of schizophrenic symptoms (scored according to the five-dimensional model of Toomey et al. [28]), the distress due to the subjective experience of negative symptoms, and the degree of subjectively-felt cognitive-affective vulnerability (i.e. basic symptoms).
RESULTS: Principal component analysis revealed CDSS to include three main factors, namely: "depression-hopelessness" (factor I), "guilty idea of reference-pathological guilt" (factor II) and "early wakening" (factor III). Whereas the last factor did not correlate with any of the other psychopathological domains, the first two factors revealed multiple correlations with both diagnostic symptoms and subjective experiences.
CONCLUSIONS: The results confirm the threefold factorial structure of the CDSS previously reported by the authors of the scale and could shed further light on the psychopathological nature of the components of depression in schizophrenia. The specific correlation patterns with diagnostic and subjective psychopatholgy substantiate the clinical distinction between a general depression factor ("depression-hopelessness") and a cognitive-guilt factor ("guilty idea of reference-pathological guilt").

Entities:  

Mesh:

Year:  2005        PMID: 16356690     DOI: 10.1016/j.eurpsy.2005.07.001

Source DB:  PubMed          Journal:  Eur Psychiatry        ISSN: 0924-9338            Impact factor:   5.361


  9 in total

1.  Negative symptoms and their association with depressive symptoms in the long-term course of schizophrenia.

Authors:  Wolfram An der Heiden; Anne Leber; Heinz Häfner
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2016-04-23       Impact factor: 5.270

2.  Thematic analysis of the raters' experiences administering scales to assess depression and suicide in Arab schizophrenia patients.

Authors:  Iman Amro; Suhaila Ghuloum; Samer Hammoudeh; Yahya Hani; Arij Yehya; Hassen Al-Amin
Journal:  BMC Psychiatry       Date:  2022-10-21       Impact factor: 4.144

3.  Testing trait depression as a potential clinical domain in schizophrenia.

Authors:  Joshua Chiappelli; Peter Kochunov; Katherine DeRiso; Kavita Thangavelu; Hemalatha Sampath; Florian Muellerklein; Katie L Nugent; Teodor T Postolache; William T Carpenter; L Elliot Hong
Journal:  Schizophr Res       Date:  2014-08-27       Impact factor: 4.939

Review 4.  The role of rumination in illness trajectories in youth: linking trans-diagnostic processes with clinical staging models.

Authors:  A B Grierson; I B Hickie; S L Naismith; J Scott
Journal:  Psychol Med       Date:  2016-06-29       Impact factor: 7.723

5.  The Association between Anomalous Self-experiences, Self-esteem and Depressive Symptoms in First Episode Schizophrenia.

Authors:  Elisabeth Haug; Merete G Øie; Ole A Andreassen; Unni Bratlien; Kristin L Romm; Paul Møller; Ingrid Melle
Journal:  Front Hum Neurosci       Date:  2016-11-07       Impact factor: 3.169

6.  Validation of the Arabic Version of Calgary Depression Scale for Schizophrenia.

Authors:  Yahya Hani; Suhaila Ghuloum; Ziyad Mahfoud; Mark Opler; Anzalee Khan; Arij Yehya; Abdulmoneim Abdulhakam; Samer Hammoudeh; Azza Al-Mujalli; Reem Elsherbiny; Hassen Al-Amin
Journal:  PLoS One       Date:  2016-09-01       Impact factor: 3.240

7.  Depressive symptoms in first episode psychosis: a one-year follow-up study.

Authors:  Nasrettin Sönmez; Kristin Lie Romm; Ole A Andreasssen; Ingrid Melle; Jan Ivar Røssberg
Journal:  BMC Psychiatry       Date:  2013-04-05       Impact factor: 3.630

8.  The latent structure of depressive symptoms across clinical high risk and chronic phases of psychotic illness.

Authors:  Teresa Vargas; Anthony O Ahmed; Gregory P Strauss; Cassandra M Brandes; Elaine F Walker; Robert W Buchanan; James M Gold; Vijay A Mittal
Journal:  Transl Psychiatry       Date:  2019-09-16       Impact factor: 6.222

9.  Dispositional Mindfulness and Psychotic Symptoms in Schizophrenia Spectrum Disorders: The Mediating Roles of Rumination and Negative Emotion.

Authors:  Angie Ho Yan Lam; Yee Tak Derek Cheung; Kwan Ho Wong; Sau Fong Leung; Wai Tong Chien
Journal:  Neuropsychiatr Dis Treat       Date:  2022-01-11       Impact factor: 2.570

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.